Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1995-06-02
1997-07-08
Feisee, Lila
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
4241331, 4241341, 4241351, 4241531, 514 12, 530350, 5303873, 5303887, 5303911, C12P 2108, A61K 39395, A61K 3944, C07K 1628
Patent
active
056458177
ABSTRACT:
The present invention describes granulocyte-binding antibody constructs, which were derived from the monoclonal mouse antibody MAk BW 250/183 (EP-A1-0 388 914), as well as a process for their preparation and their use.
REFERENCES:
Burgess et al. Journal of Cell Biology 111: 2129-2138 1990.
Gillies et al (1990) Human Antibod. and Hybridomas 1(1) p. 47.
Lazar et al. Molecular and Cellular Biology 1988 p. 1247.
Tao et al. Journal of Immunology vol. 143 2595 1989.
Harris et al. TibTech. vol. 11 (1993.) p. 42.
Bird et al. Trends in BioTech. 9, pp. 132-137 (1991).
D'Amico et al. Nuc. Med Biol. 18(1) 145 (1991).
Joseph et al. Nuclear Med Comm 9, 763-769 (1988).
Queen et al. PNAS. (vol. 86) 10029, 1989.
Huse (Antibody Engineering) Borrebaeck 1992 p. 103.
Emery et al. Exp. Opin Invest Drugs 3(3) 241-25 1994.
Cunningham et al. TibTech Apr. 1992 vol. 10 (4) 112-113.
Ward (Antibody Engineering) Borrebaeck ed. 1992. p. 121.
Wu and Kabat, "Sequences of Proteins of Immunological Interest," U.S. Department of Health and Human Services (1991), pp. 104, 243 and 318.
"The Three-Dimensional Structure of the Fab' Fragment of a Human Myeloma Immunoglobulin at 2.0-A Resolution"--Poljak, et al., Proc. Nat. Acad. Sci. USA 71(9): 3440-3444 (1974).
"Evolution of Human Immunoglobulin .kappa. J Region Genes*", Hieter, et al. The Journal of Biological Chemistry, 257(3): 1516-1522 (1982).
"Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids", Lee et al., Nature 294: 228-232 (1981).
"Production of functional chimaeric mouse/human antibody" Boulianne et al. Nature 312:643-646 (1984).
"Immunohistochemical Localization and Molecular Characteristics of Three Monoclonal Antibody-Defined Epitopes Detectable on Carcinoembryonic Antigen (CEA)", Bosslet et al., Int. J. Cancer 36:75-84 (1985).
"Replacing the complementarity-determining regions in a human antibody with those from a mouse", Jones et al., Nature, 321: 522-525 (1986).
"A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells", Bosslet et al., Cancer Immunol Immunother 23:185-191 (1986).
"The Immunogenicity of Chimeric Antibodies", Brueggemann, et al., J. Exp. Med. 170:2153-2157 (1989).
"A Novel Approach To Tc-99m-Labeled Monoclonal Antibodies", Schwarz et al., J. Nucl. Med. 28(4):721 (1987).
"Reshaping Human Antibodies: Grafting an Antilysozyme Activity", Verhoeyen et al., Science, 239:1534-1536 (1988).
"Reshaping human antibodies for therapy", Riechmann et al., Nature 332(6162): 323-327 (1988).
Bosslet Klaus
Seemann Gerhard
Behringwerke Aktiengesellschaft
Feisee Lila
Lucas John
LandOfFree
Granulocyte-binding antibody constructs, their preparation and u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Granulocyte-binding antibody constructs, their preparation and u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Granulocyte-binding antibody constructs, their preparation and u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2407507